Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

CTSU E2607 A Phase II Trial of Dasatinib in KIT-Positive Patients with Unresectable Locally Advanced or Stage IV Mucosal, Acral and Vulvovaginal Melan


Collapse Overview 
Collapse sponsor award id
E2607


Collapse Biography 

Collapse Time 
Collapse start date
2012-06-26